Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model

By Ayalasomayajula S.P.   Kompella U.B.  

European Journal of Pharmacology, Vol. 458, Iss. 3, 2003-01 ,pp. : 283-289

Elsevier

Access to resources Recommend Favorite

Cellular uptake on N- and C-termini conjugated FITC of Rath cell penetrating peptides and its consequences for gene-expression profiling in U-937 human macrophages and HeLa cervical cancer cells

By Kuo Jung-hua Steven   Lin Chia-Wei  

Journal of Drug Targeting, Vol. 21, Iss. 9, 2013-11 ,pp. : 801-808

Informa Healthcare

Access to resources Recommend Favorite

Silymarin augments human cervical cancer HeLa cell apoptosis via P38/JNK MAPK pathways in serum-free medium

By Huang Qing  

Journal of Asian Natural Products Research, Vol. 7, Iss. 5, 2005-10 ,pp. : 701-709

Taylor & Francis Ltd

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib: A Selective Cyclo-Oxygenase-2 Inhibitor

By Davies N.M.  

Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. : 225-242

Adis International

Access to resources Recommend Favorite

Transforming Growth Factor-&bgr;1 Induces Endothelin-1 in a Bovine Pulmonary Artery Endothelial Cell Line and Rat Lungs via cAMP

By Lee S.D.   Lee D.S.   Chun Y.G.   Paik S.H.   Kim W.S.   Kim D.S.   Kim W.D.   Tuder R.M.   Voelkel N.F.  

Pulmonary Pharmacology & Therapeutics, Vol. 13, Iss. 6, 2000-12 ,pp. : 257-265

Academic Press

Access to resources Recommend Favorite